 | | | | Drugmakers Bristol Myers Squibb Co and AbbVie Inc told California officials that they plan to cut up to 360 jobs there in unrelated moves, according to notices filed with the state that were made public earlier this week. | | | | | | Two COVID-19 antibody therapies are no longer recommended by the World Health Organization (WHO), on the basis that Omicron and the variant's latest offshoots have likely rendered them obsolete. | | | | | | Around 90 countries where monkeypox is not endemic have reported outbreaks of the viral disease, which the World Health Organization has declared a global health emergency, as confirmed cases crossed 60,200 and non-endemic countries reported their first related deaths. | | | | | | Mainland China's southwestern municipality of Chongqing reported one case of the monkeypox virus infection on Friday in one individual who arrived in the country from abroad, marking the country's first known monkeypox infection. | | | | | | France's national health body warned on Friday of a resurgence of COVID-19 cases in the country, and urged people to continue to get vaccinated to protect themselves against the virus. | | | | | | Bahrain has detected its first monkeypox case, the state news agency BNA said on Friday, citing the health ministry. | | | | | | Europe's medicines regulator has backed using AstraZeneca's preventative COVID-19 therapy as a treatment for the disease and also endorsed another medicine as preventative option for another common virus. | | | | | | AstraZeneca said on Friday its drug for preventing infant RSV, Beyfortus (nirsevimab), was recommended for approval in the European Union by a European Medicines Agency committee. | | | | | | Taiwan is eyeing an earlier end to its mandatory quarantine for all arrivals and has been making relevant preparations, Premier Su Tseng-chang said on Friday, as the government continues to ease controls put in place to contain the spread of COVID-19. | | | | | | Makers of the top selling drugs in the United States are costing patients billions of dollars and worsening a drug pricing crisis by abusing the U.S. patent system to stifle competition and inflate prices, a consumer group said on Thursday, | | | | | |
